Healthy Skepticism Library item: 6731

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Follow-up: Whitehall’s promotion of Robitussin (dextromethorphan and/or guaiphenesin and/or pseudoephedrine)
MaLAM Australian News 1997 Jan-Feb; 5:(1-2):4

Abstract:

Whitehall has not responded to MaLAM’s earlier letter about its promotion of the Robitussin range of products for coughs and colds which it distributes in Australia. The company that makes these products Wyeth-Ayerst promised to provide information but has not done so.

Keywords:
*analysis/Australia/developed countries/Robitussin/Whitehall/Wyeth/ cough/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/company responses/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES